About Xitogen Technologies
Xitogen Technologies is a Healthcare company based in Suzhou (China) founded in 2013, and was acquired by Beckman Coulter in April 2014. Flow cytometer research applications are developed for nanoscale object detection. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology.
Company details
Xitogen Technologies was established in 2013 in Suzhou, China, within the biotechnology sector. Research applications for flow cytometry are developed, focusing on detection technologies. The XTG-1600 cytometer, with its compact design, is produced to identify objects in the 100-nanometer range, including viruses, bacteria, microparticles, and cell organelles. Operations center on advancing tools for scientific and medical research in this field.
- Headquarters Suzhou, China
- Stage Acquired
- SectorsHealthcare
- Website xitogen.com
- Acquired by Beckman Coulter (Apr 2014)
- Investors
- Acquired byBeckman Coulter
(Apr 2014)
Investors in Xitogen Technologies
Xitogen Technologies has secured backing from 1 investor. Prominent investors backing the company include Beckman Coulter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical diagnostic products are manufactured for biomedical testing. | 1935 | beckmancoulter.com | Brea, United States |
Investor details for Xitogen Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Xitogen Technologies
2 dated milestones of Xitogen Technologies across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Xitogen Technologies is founded.
- Exit Acquired by Beckman Coulter.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Xitogen Technologies
Xitogen Technologies was founded in 2013.
Xitogen Technologies is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Xitogen Technologies was established in 2013 in Suzhou, China, within the biotechnology sector. Research applications for flow cytometry are developed, focusing on detection technologies. The XTG-1600 cytometer, with its compact design, is produced to identify objects in the 100-nanometer range, including viruses, bacteria, microparticles, and cell organelles. Operations center on advancing tools for scientific and medical research in this field.
Xitogen Technologies has 1 investor. Key investors include Beckman Coulter.
Yes. Xitogen Technologies was acquired by Beckman Coulter in April 2014.
